Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia 7Lymphoma 3Sezary Syndrome 2Mycosis Fungoides 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Large Granular Lymphocytic 2Waldenstrom Macroglobulinemia 1Recurrence 1Neoplasms 1Mucositis 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Prolymphocytic, T-Cell 1Leukemia, Prolymphocytic, B-Cell 1Leukemia, Biphenotypic, Acute 1Immunoblastic Lymphadenopathy 1

Interventions

Cyclophosphamide 44Peripheral Blood Stem Cell Transplantation 25fludarabine phosphate 24Doxorubicin 23Etoposide 22Vincristine 21Prednisone 20Whole-Body Irradiation 19Rituximab 18Filgrastim 16Brentuximab Vedotin 15Mycophenolic Acid 14Cyclosporine 14Busulfan 14Methotrexate 12Radiotherapy 11Cytarabine 11Carboplatin 10Melphalan 9Ifosfamide 9Antilymphocyte Serum 9Tacrolimus 8Methylprednisolone 8Gemcitabine 8Bortezomib 8Dexamethasone 7Vorinostat 6Everolimus 6Crizotinib 6romidepsin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lymphoma, Large-Cell, Anaplastic × nelarabine × Clear all
NCT00005080 2013-01-16

506U78 in Treating Patients With Lymphoma

National Cancer Institute (NCI)

Phase 2 Completed
74 enrolled
DermatologicLymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡